Aligos Therapeutics (ALGS) EPS (Diluted) (QoQ) (2021 - 2026)
Aligos Therapeutics (ALGS) EPS (Diluted) (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | Aligos Therapeutics | 69.89 Mn | 39.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.49% |
| Mar 31, 2026 | -10.12% |
| Dec 31, 2025 | 33.87% |
| Sep 30, 2025 | -98.46% |
| Jun 30, 2025 | -130.98% |
| Mar 31, 2025 | 137.73% |
| Dec 31, 2024 | -327.08% |
| Sep 30, 2024 | -480.15% |
| Jun 30, 2024 | 114.47% |
| Mar 31, 2024 | 48.56% |
| Dec 31, 2023 | -4.65% |
| Sep 30, 2023 | 4.61% |
| Jun 30, 2023 | 18.72% |
| Mar 31, 2023 | -4.36% |
| Dec 31, 2022 | -17.72% |
| Sep 30, 2022 | 6.75% |
| Jun 30, 2022 | 44.26% |
| Mar 31, 2022 | 5.81% |
| Dec 31, 2021 | -13.86% |